Funding for this research was provided by:
Received: 19 July 2020
Accepted: 11 August 2020
First Online: 15 August 2020
Ethics approval and consent to participate
: The study was approved by the Internal Review Board of the University of L’Aquila (Italy) and patients gave written informed consent according to the Declaration of Helsinki.
: Not applicable.
: RO has received sponsorship to attend meetings from Novartis and Teva; SS had a financial relationship (lecturer or member of advisory board) with Abbott, Allergan, Novartis, Teva, and Eli Lilly; GA has received funds for congress participation from Innovet Italia Srl, Epitech Group and Lusofarmaco; MAG received funds for congress participation from IBSA; AC, IF, AG, MA, MM, FM, SV, DC, CM, and FP declare no competing interests.